Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 1346 results found. Search for [ pharmaceutical drug ]

Results 1 to 21 of 1346
Manoj Sharma
November 27, 2020
New vaccines are rarely certified for efficacy above 90 per cent. Their efficacy improves as millions are vaccinated over decades. In fact, most vaccines get certified in the 40-60 per cent efficacy band


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
The world of vaccine and drug development is being reset. Here's how Indian pharma must reinvent to lead the new era of drug discovery and research


PB Jayakumar & Joe C Mathew
New Delhi, November 25, 2020
A blow-by-blow account of how Indian vaccines are being readied


BusinessToday.In
November 24, 2020
Vardhan says it makes no sense to consider Pfizer as pharma major is yet to get approval in the US. After requisite approvals, US pharma major will have to cater to needs of its own country's population first


BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public


BusinessToday.In
November 21, 2020
Pfizer's CEO Albert Bourla confirmed the company's application and said in a video statement,  'It is with great pride and joy - and even a little relief - that I can say that our request for emergency use authorization for our COVID-19 vaccine is now in the FDA's hands.'


Shailendra Shukla
New Delhi, November 21, 2020
WHO removes Remdesivir from list of COVID-19 medicines The World Health Organization said on Friday it has suspended Gilead's remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised Covid-19 patients. \"The suspension is a signal to countries that WHO, in compliance with the treatment guidelines, does not recommend countries procure the drug for Covi...


BusinessToday.In
November 21, 2020
Pfizer that its EUA submission is supported by solicited safety data from a randomised subset of approximately 8,000 participants aged 18 years or above and unsolicited safety data from approximately 38,000 trial participants


BusinessToday.In
November 20, 2020
Adar Poonawalla said if things go according to the plan, the coronavirus vaccine will be available for vulnerable populations by January or February. And, in March or April, the vaccine will enter the market for the general public


BusinessToday.In
November 18, 2020
Pfizer and BioNTech informed that primary efficacy analysis of their coronavirus vaccine candidate showed that it was 95 per cent effective beginning 28 days after the first dose


BusinessToday.In
November 17, 2020
The Rs 6,480-crore IPO (initial public offering) of Chinese-backed drug firm Gland Pharma that closed on November 11, was merely subscribed 2.06 times


BusinessToday.In
November 16, 2020
Moderna stated that its COVID-19 vaccine candidate remains stable for 30 days at 2-degree Celsius to 8-degree Celsius, the temperature of a standard home or medical refrigerator


BusinessToday.In
November 13, 2020
Dalal Street today: IndusInd Bank, followed by SBI, L&T, Axis Bank, HDFC twins, Kotak Bank and ICICI Bank were among the top losers today. On the other hand, Asian Paints, Reliance Industries, Titan, Bajaj Finance and Sun Pharma were trading with gains


BusinessToday.In
November 11, 2020
The major hurdle for the vaccine is storage and distribution. Pfizer's COVID-19 vaccine candidate needs to be stored at temperatures of minus 70 degrees Celsius (-94 F) or below


BusinessToday.In
November 9, 2020
India Stock Market Highlights Today: All Sensex stocks were trading in green led by ICICI Bank, Infosys, HCL Technologies, Axis Bank, HDFC Bank and Hindustan Unilever


PTI
November 8, 2020
The drug firm has earmarked digital adoption and resilient operations as first of the key priorities for the coming quarters to achieve sustained growth


BusinessToday.In
November 7, 2020
Recently, Indian pharma companies are witnessing rampant cyber threats as they are delivering affordable medicines on a large scale amid the coronavirus pandemic


Chitranjan Kumar
November 3, 2020
Sun Pharma Q2 results: Revenue from operations grew 5.29 per cent to Rs 8,553.13 crore in Q2 FY21, from Rs 8,123.35 crore in the corresponding quarter


BusinessToday.In
November 3, 2020
German biotech firm CureVac has revealed its vaccine candidate has triggered an immune response during its phase 1 trials. The UK government has also started the process of the rolling review of AstraZeneca's candidate


PB Jayakumar
November 3, 2020
Zydus today said it has filed an Investigational New Drug (IND) application for 'ZYIL1', an oral drug candidate, that has found to be effective in pre-clinic studies to control inflammation in COVID-19 related diseases


PAGES 1 OF 68  12345